期刊文献+

基因组DNA甲基化在同型半胱氨酸致平滑肌细胞增殖的作用机制研究 被引量:3

The Mechanism of Genomic DNA Methylation in Hcy Induced VSMCs Proliferation
下载PDF
导出
摘要 目的探讨基因组DNA甲基化变化在Hcy致VSMCs增殖的作用机制。方法原代培养VSMCs并鉴定,用0、50、100、200、500μM浓度Hcy干预,MTT法检测VSMCs活性;SssI甲基转移酶法分析基因组DNA甲基接受能力,甲基化敏感性限制性内切酶法分析基因组DNA甲基接受能力及DNA甲基转移酶活性。结果 MTT法表明在50μM Hcy时,VSMCs活性明显增加,其余活性下降,与各浓度组并不呈量效依赖关系;Hcy可增加DNA甲基接受能力,以50μM Hcy组效应最显著(P<0.05);HpalI限制核酸内切酶消化,与对照组比较,基因组DNA甲基化接受能力减少了50.1%、41.7%、46.1%和25.5%(50、100、200、500μM Hcy组),BssHII限制核酸内切酶消化后,基因组DNA甲基化接受能力减少了约25.5%、18.1%、17.4%和18.0%(50、100、200、500μM Hcy组)。结论 Hcy引起VSMCs基因组DNA去甲基化是平滑肌细胞增殖的重要机制之一,其效应偏重发生于CpG二核苷酸序列,CpG岛所受影响相对较小,其最大效应在50μMHcy组,且无明显的量-效依赖关系。 Objective To investigate the mechanism of Genomic DNA methylation in Hcy induced VSMCs proliferation.Methods 0,50,100,200,500μM concentrations of Hcy were added into the primary cultured VSMCs.Proliferative activity of VSMCs measured by MTT;genomic DNA methyl acceptance was analyzed with SssI methyltransferase enzyme method;genomic DNA methyl acceptance and Determination of DNA methyltransferase activety were determined with Methylation-sensitive restriction enzyme method;changes in genomic DNA methylation from multiple level were detected with repeated experiments.Results MTT test showed that 50mM Hcy increased the proliferation viability of VSMCs while 100,200 and 500 mM Hcy decreased the viable cells count;The impacts of various concentration of Hcy on the one-carbon methyl-group transferring metabolism didn't show dose-effect relationship.50mM Hcy could significantly increased genomic DNA methyl acceptance(P0.05).In HpaII digestion group,its reductions in methylation-accepting capacity was 50.1%,41.7%,46.1% and 25.5%(50,100,200 and 500mM Hcy respectively) compared with the undigested DNA.The methylation-accepting capacity in BssHII cutting groups declined just approximately 25.5%,18.1%,17.4% and 18.0%(50,100,200 and 500mM Hcy respectively) compared with the undigested DNA.Conclusion Hcy could lead to genomic DNA hypomethylation in VSMCs and it is maybe an important mechanism for VSMCs proliferation.
出处 《宁夏医科大学学报》 2010年第7期751-754,F0002,共5页 Journal of Ningxia Medical University
基金 国家自然科学基金项目(30960124) 宁夏自然科学基金项目(NZ1086) 宁夏医科大学面上项目(20070618)
关键词 同型半胱氨酸 平滑肌细胞增殖 基因组DNA甲基化 artherosclerosis homocysteine DNA methylation
  • 相关文献

参考文献11

  • 1Boushey CJ, Beresford SAA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes [ J ]. JAMA, 1995,274:1049 - 1057.
  • 2Eikelboom JW, Lonn E, Genest J J, et al. Homocysteine and cardiovascular disease : a critical review of the epidemiologic evidence [ J ]. Ann Intern Med, 1999, 131 : 363 -375.
  • 3Jiang YD, Zhang JZ, Huang Y, et al. Homocysteine - mediated expression of SAHH, DNMTs, MBD2, and DNA- hypomethylation potential pathogenic mechanismin VSMCs [ J ]. DNA Cell Biol,2007,26 ( 8 ) : 603 - 611.
  • 4Turhan H, Erbay AR, Yasar AS, et al. Plasma homocysteine levels in patients with isolated coronary artery ectasia[ J ]. Cardiol,2005,104 (2): 158 - 162.
  • 5Lund G, Andersson L, Lauria M,et al, DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E [ J ]. J Biol Chem, 2004 ,279 ( 28 ) :29147 - 2954.
  • 6Esteler M. CpG island methylation and histone modifications, biology and clinical significance [ J ]. Ernst Schering Res Found Workshop,2006, (57) : 115 - 126.
  • 7Hiltunen MO, Turunen MP, Hakkinen TP, et al. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions[J]. Vasc Med,2002,7( 1 ) :5 - 11.
  • 8Lawrence de Koning AB, Werstuck GH, Zhou J, et al. Hyperhomocysteinemia and its role in the development of atherosclerosis [ J ]. Clin Biochem, 2003,36 ( 6 ) : 431 - 441.
  • 9Yan SK, Chang T, Wang H, et al. Effects of hydrogen sulfide on homocysteine - induced oxidative stress in vascular smooth muscle cells[ J]. Biochem Biophys Res Commun,2006 ,351 (2) :485 -491.
  • 10董剩勇,舒茂琴.高同型半胱氨酸血症与心血管疾病的研究进展[J].临床心血管病杂志,2005,21(2):123-125. 被引量:12

二级参考文献16

  • 1McCully K S.Vascular poathology of homocysteinemia:implications for the pathologenesis of arteriosclerosis.Am J Pathol,1969,56:111-128.
  • 2Chan S J,Chang C N,Hsu J C,et al.Homocysteine,vitaminB(6),and lipid in cardiovascular disease.Nutrition,2002,18:595-598.
  • 3Ueland P M,Refsum H, Brattstrom L, Plasma homocysteine and cardiovascular disease.In:Francis RB Jr,ed.Atherosclerotic cardiovascular disease,hemostasis,and endthelial function.New York:Marcel Dekker,1992.183-236.
  • 4Yoo J H,Chor G D,Kang S S.Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia.Arterioscler Thromb Vasc Biol,2000,20:1921-1925.
  • 5Stehouwer C D,van-Gulderier C.Does homocysteine cause hpyertension? Clin Chem Lad Med,2003,41:1408-1411.
  • 6Ajabnoor M A,AL-Ama M N,Banjar Z,et al.Homocysteine level and other biochemical parameters in cardiovascular disease patients with diabetes mellitus.Med Sci Monit,2003,9:CR523-527.
  • 7Koulouridis E,Tzilianos M,Katsarou A,et al.Homocysteine and C-reactive prote in levels in haemodialysis patient.Int Urol Nephrol,2001,33:207-215.
  • 8Religa D,Styczynska M,Peplonska B,et al.Homocysteine, apolipoproteine E and meth ylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment.Dement Geriatr Cogn Disord,2003,16:64-70.
  • 9Chen C,Conklin B S, Ren Z,et al.Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries.J Surg Res,2002,102:22-30.
  • 10Wang H,Jiang X,Yang F,et al.CyclinA transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition.Blood,2002, 99:939-945.

共引文献11

同被引文献31

  • 1Handy DE, Castro R, Loscalzo J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease [ J ]. Circulation, 2011,123(19) :2145 -2156.
  • 2Lorenzen JM, Martino F,Thum T. Epigenetic modifications in cardio- vascular disease[ J ]. Basic Research in Cardiol,2012,107 (2) :245.
  • 3Woo CW, Prathapasinghe GA, Siow YL, et al. Hyperhomocysteine- mia induces liver injury in rat : protective effect of folic acid supple- mentation [ J ]. Biochimica et Biophysica Acta,2006,1762 (7) : 656 - 665.
  • 4Liu C, Wang Q, Guo H, et al. Plasma S -adenosyl homocysteine is a better biomarker of atherosclerosis than homocysteine in apolipopro- tein E - deficient mice fed high dietary methionine [ J ]. J Nutri,2008,138(2) :311 -315.
  • 5Cacciapuoti F. Hyper -homocysteinemia:a novel risk factor or a power- ful marker for cardiovascular diseases? Pathogenetic and therapeutical uncertainties[J]. J Thrombo Thromboly,2011,32( 1 ) :82 -88.
  • 6Yi P, Melnyk S, Pogribna M, et al. Increase in plasma homocysteine associated with parallel increases in plasma S - adenosylhomocys- teine and lymphocyte DNA hypomethylation [ J ]. J Biolo Chem, 2000,275 ( 38 ) :29318 - 29323.
  • 7Wangsri S ,Subbalekha K,Kitkumthom N, et al. Patterns and possible roles of LINE - 1 methylation changes in smoke - exposed epithelia [J]. Plos One,2012,7(9):45292.
  • 8Cash HL, McGarvey ST, Houseman EA, et al. Cardiovascular disease risk factors and DNA methylation at the Line - 1 repeat region in pe- ripheral blood from Samoan Islanders[J]. Epigenetics :official journal of the DNA methylation society,2011,6(10) :1257 - 1264.
  • 9孙颖,李敏,王翠英,秦明照,常志文.非诺贝特对载脂蛋白E基因敲除小鼠动脉组织CXCL16表达的影响[J].中国动脉硬化杂志,2010,18(3):203-207. 被引量:4
  • 10陈梅玲,林小慧,李清华,刘开祥,曾爱源.动脉粥样硬化性脑梗死患者血浆同型半胱氨酸水平及亚甲基四氢叶酸还原酶基因多态性[J].中国动脉硬化杂志,2010,18(9):733-736. 被引量:20

引证文献3

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部